| Cardiovascular Risk Management |
1 |
1 |
| Genomic Medicine |
0 |
0.98 |
| Niacin |
0 |
0.99 |
| Cardiovascular Imaging |
0 |
0.31 |
| Europe |
0 |
0.26 |
| Genetics |
0 |
0.26 |
| Cerebrovascular Accident |
0 |
0.2 |
| Healthcare and Medical Technology |
0 |
0.2 |
| Myocardial Infarction (MI) |
0 |
0.2 |
| Grant |
0 |
0.13 |
| Plasma |
0 |
0.13 |
| UK Site Content |
0 |
0.13 |
| Adherence |
0 |
0.07 |
| Adhesion |
0 |
0.07 |
| Angiography |
0 |
0.07 |
| Blood |
0 |
0.07 |
| California |
0 |
0.07 |
| Cardiovascular disease |
0 |
0.07 |
| Clinical Research |
0 |
0.07 |
| Dietary Supplements |
0 |
0.07 |
| Environmental Medicine |
0 |
0.07 |
| Epidemiology |
0 |
0.07 |
| Heart |
0 |
0.07 |
| Infarction |
0 |
0.07 |
| Lung |
0 |
0.07 |
| Meta-Analysis |
0 |
0.07 |
| Metabolism |
0 |
0.07 |
| Ohio |
0 |
0.07 |
| Referral |
0 |
0.07 |